A government report lends credence to the notion of “two Indias”, or the distinction between “India” and “Bharat” – a theme often debated in recent years. At a time when urban India is growing and policy makers have expressed clear preference for the trend, this report, by National Sample Survey Organisation (NSSO), brings India’s deep urban-rural divide into focus, showing disparities in scale and levels of expenditure and consumption and, equally...

Health activists say new policy may not address the weaknesses in ongoing routine immunisation programmes and would flood poor countries with new vaccines When the global health leaders meet in Geneva from May 21 to 26 for the World Health Organization's 65th General Assembly, introducing new vaccines in the low- and middle-income countries would be high on their agenda. A “global draft vaccine action plan”, available on WHO's website, details the implementation...

A campaign to help the elderly spend the evening of their lives with dignity and without want is being launched by Pension Parishad with a dharna in Delhi from May 7th to May 11th 2012 at Jantar Mantar, New Delhi. The idea is straight and simple, and is something whose time has come. Just read on and reach the venue for more information and interviews with the campaign participants.   “One...

Entrepreneurs and investors , who had only recently found innovative ways to invest in education as a business , are concerned about the financial impact of the Supreme Court ruling last week upholding the Right to Education Act. All schools, except minority unaided ones , will now have to set aside 25% of seats for poor students .  While most investors welcome the move , they also worry about funding the...

India's decision this month to produce Germany-based multinational Bayer's anti-cancer drug Nexavar, in the first use of "compulsory licensing" in South Asia, will save lives but also raises intricate questions. Under the compulsory licensing process, a government can under World Trade Organization (WTO) rules bypass a patent owner's rights after three years and order the manufacture and sale of life-saving medicines at much cheaper cost than by obtaining the medicine from...